HM Payson & Co’s Bio-Techne TECH Stock Holding History

HM Payson & Co’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$480	–	1142
2024 Q3	$480	Buy	+6	New	+$451	﹤0.01%	1070
2023 Q2	–	Sell	-104	Closed	-$7.72K	–	1054
2023 Q1	$7.72K	Hold	104	–	–	﹤0.01%	819
2022 Q4	$8.62K	Hold	104	–	–	﹤0.01%	758
2022 Q3	$7K	Hold	104	–	–	﹤0.01%	825
2022 Q2	$9K	Hold	104	–	–	﹤0.01%	827
2022 Q1	$11K	Hold	104	–	–	﹤0.01%	835
2021 Q4	$13K	Hold	104	–	–	﹤0.01%	834
2021 Q3	$13K	Hold	104	–	–	﹤0.01%	809
2021 Q2	$12K	Hold	104	–	–	﹤0.01%	810
2021 Q1	$10K	Hold	104	–	–	﹤0.01%	868
2020 Q4	$8K	Buy	104 +60	+136%	+$4.34K	﹤0.01%	884
2020 Q3	$3K	Buy	+44	New	+$2.86K	﹤0.01%	930
2020 Q1	–	Sell	-1,200	Closed	-$66K	–	977
2019 Q4	$66K	Hold	1,200	–	–	﹤0.01%	536
2019 Q3	$59K	Hold	1,200	–	–	﹤0.01%	563
2019 Q2	$63K	Buy	+1,200	New	+$60.5K	﹤0.01%	560

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

HM Payson & Co's TECH Position: Q4 2024 in Review

HM Payson & Co sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 6 shares — an estimated $480 sold.

HM Payson & Co first reported a position in TECH in Q2 2019 and held it in 15 quarters. The position peaked at $66K in Q4 2019. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

HM Payson & Co reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
HM Payson & Co sold 6 Bio-Techne shares in Q4 2024, an estimated $480.
HM Payson & Co first reported a position in Bio-Techne in Q2 2019 and held it in 15 quarters.
HM Payson & Co's Bio-Techne position peaked at $66K in Q4 2019.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on HM Payson & Co's 13F filing for Q4 2024, filed 7 Feb 2025.